Biosimilars Market, Size, Revenue, Insights to Reach USD 143.97 Billion by 2032 | IMR
Global Biosimilars Market Size Was Valued at USD 34.01 Billion in 2023 and is Projected to Reach USD 143.97 Billion by 2032, Growing at a CAGR of 17.39% From 2024-2032. Biosimilars are biologic medical products highly similar to already approved reference biologics, offering comparable safety, efficacy, and quality. Unlike generic drugs, which are identical chemical copies of branded drugs,...
0 Комментарии 0 Поделились 0 Отзывы
Реклама
Реклама